Concepedia

Juliana Ianus

JI

8

Publications

2.8K

Citations

8

H-Index

2003

Active since

Affiliations

Janssen (United States)(Current)

Rotterdam University of Applied Sciences

Bayer (Germany)

Juliana Ianus is an author at Janssen (United States) specializing in virology, clinical outcomes, and infection control.

Top concepts

Publications per year

2003–2023

8

Publications

8

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

C. Michael Gibson, Roxana Mehran, Christoph Bode et al. · New England Journal of Medicine · 2016 · 1.5K citations · Full text

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Paul J. Hesketh, Steven M. Grunberg, Richard J. Gralla et al. · Journal of Clinical Oncology · 2003 · 770 citations

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

Gary J. Noel, Karen Bush, Partha Bagchi et al. · Clinical Infectious Diseases · 2008 · 267 citations

Antiemetic efficacy of the neurokinin‐1 antagonist, aprepitant, plus a 5HT<sub>3</sub> antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high‐dose cisplatin

Richard J. Gralla, Ronald de Wit, Alexandra D. Carides et al. · Cancer · 2005 · 91 citations · Full text

Efficacy and Safety of a Neurokinin-1 Receptor Antagonist in Postmenopausal Women With Overactive Bladder With Urge Urinary Incontinence

Stuart A. Green, Achilles Alon, Juliana Ianus et al. · The Journal of Urology · 2006 · 91 citations

Rows per page

1–5 of 8